Join to View Full Profile
200 West Arbor Dr Mc 0949Ucsd Medical CenterSan Diego, CA 92103
Phone+1 858-622-2028
Dr. Aisen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1979 - 1982
Columbia University Vagelos College of Physicians and SurgeonsClass of 1979, MD
Certifications & Licensure
CA State Medical License 2008 - 2025
DC State Medical License 1999 - 2010
VA State Medical License 1999 - 2002
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- Cortico-limbic volume abnormalities in late life depression are distinct from β amyloid and white matter pathologies.R Scott Mackin, Emma Rhodes, Michelle Kassel, Maria Kryza-Lacombe, Emily Burns
Molecular Psychiatry. 2025-04-01 - Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials.Dustin B Hammers, Jane Musema, Ani Eloyan, Maryanne Thangarajah, Alexander Taurone
The Journal of Prevention of Alzheimer's Disease. 2025-04-01 - Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts.Julien Lagarde, Piyush Maiti, Daniel R Schonhaut, Ganna Blazhenets, Jiaxiuxiu Zhang
Annals of Neurology. 2025-03-17
Press Mentions
Small Study Hints Anti-Amyloid Therapy May Keep Alzheimer’s Symptoms at Bay in Certain PatientsMarch 21st, 2025- Alzheimer’s Drug Slows Cognitive Decline,November 30th, 2022
- New Alzheimer’s Drug Slows Cognitive DeclineNovember 30th, 2022
- Join now to see all
Grant Support
- Alzheimer's Clinical Trials Consortium (ACTC)UNIVERSITY OF SOUTHERN CALIFORNIA2017–2028
- Alzheimer's Clinical Trials Consortium (ACTC)UNIVERSITY OF SOUTHERN CALIFORNIA2017–2028
- Randomized Double Blind, Placebo Controlled, Parallel Group Trial to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease over 18 MonthsCOGNITION THERAPEUTICS, INC.2020–2027
- API A4 Alzheimer's Prevention TrialBANNER HEALTH2018–2025
- Combination anti-amyloid therapy for preclinical Alzheimer's diseaseUNIVERSITY OF SOUTHERN CALIFORNIA2018–2025
- Long-Term Nicotine Treatment of Mild Cognitive ImpairmentVANDERBILT UNIVERSITY MEDICAL CENTER2015–2025
- Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Open-Label Extension StudyBRIGHAM AND WOMEN'S HOSPITAL2019–2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
